NCT00062582 Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110) Status COMPLETED Phase PHASE3
NCT00061022 Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Status COMPLETED Phase PHASE3
NCT00060489 Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression Status COMPLETED Phase PHASE3
NCT00055731 Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse Status COMPLETED Phase PHASE3
NCT00055471 A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00054691 ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin Status COMPLETED Phase PHASE2
NCT00052169 Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT00044707 Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide Status COMPLETED Phase PHASE2
NCT00044694 Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT00044668 Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination Status COMPLETED Phase PHASE3
NCT00042601 Evaluation of the Effect of Pramlintide on Satiety and Food Intake Status COMPLETED Phase PHASE2
NCT00042458 Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control Status COMPLETED Phase PHASE3
NCT00039026 Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea Status COMPLETED Phase PHASE3
NCT00039013 Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin Status COMPLETED Phase PHASE3
NCT00035984 Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3